respiratory

Mixed results from Roche’s key new drugs in Q1

https://pharmaphorum.com/news/mixed-results-from-roches-key-new-drugs-in-q1/

FDA approves expanded use for GSK’s COPD triple therapy

https://pharmaphorum.com/news/fda-approves-expanded-use-for-gsks-copd-triple-therapy/

Sanofi makes double EU filing for cancer and asthma drugs

https://pharmaphorum.com/news/sanofi-makes-double-eu-filing-for-cancer-and-asthma-drugs/

Owlstone launches breath biopsy kits

https://pharmaphorum.com/digital/owlstone-launches-breath-biopsy-kits/

Verona to take COPD hopeful into phase 3

https://pharmaphorum.com/market-access-2/verona-to-take-copd-hopeful-into-phase-3/

FDA to review Sanofi’s Dupixent in asthma

https://pharmaphorum.com/news/fda-review-sanofis-dupixent-asthma/

Vertex’s latest cystic fibrosis combination approved in US

https://pharmaphorum.com/news/vertexs-latest-cystic-fibrosis-combination-approved-us/

Owlstone wins funding for IPF lung disease breathalyser test

https://pharmaphorum.com/news/uks-owlstone-wins-funding-lung-disease-breathalyser-test/

AZ boosted by COPD triple inhaler results

https://pharmaphorum.com/news/az-boosted-copd-triple-inhaler-results/

«< 3 4 5 6 7 >»

Close in 10 seconds

Pharmaphorum.com

Search